Date Filed | Type | Description |
08/10/2023 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Granted 156,250 shares
@ $0 Sold 31,250 shares
@ $2.2, valued at
$68.8k
|
|
12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2022 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Granted 202,500 shares
@ $0 |
|
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/24/2021 |
4
| BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Unknown transaction of 10,000 shares
@ $0 Disposed/sold 10,000 options to buy
@ $4.8, valued at
$48k
Disposed/sold 10,000 options to buy
@ $2.7, valued at
$27k
Disposed/sold 10,000 options to buy
@ $5.21, valued at
$52.1k
|
|
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2020 |
3/A
| BIGHAM MICHAEL (Director) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp |
12/15/2020 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Sold 18,337 shares
@ $6.95, valued at
$127.4k
Sold 26,063 shares
@ $6.71, valued at
$174.9k
|
|
12/08/2020 |
3
| BIGHAM MICHAEL (Director) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
11/16/2020 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Granted 75,000 shares
@ $0 Sold 26,250 shares
@ $5.93, valued at
$155.7k
|
|
06/05/2020 |
4
| BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 5,000 shares
@ $0 Granted 10,000 options to buy
@ $2.7, valued at
$27k
|
|
05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2019 |
4
| BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 10,000 options to buy
@ $4.8, valued at
$48k
|
|
02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Sold 8,400 shares
@ $6.76, valued at
$56.8k
|
|
10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Sold 22,500 shares
@ $9.97, valued at
$224.3k
|
|
06/07/2018 |
4
| BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns:
| Granted 10,000 options to buy
@ $27.98, valued at
$279.8k
|
|
04/10/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Sold 8,700 shares
@ $12.7, valued at
$110.5k
|
|
04/05/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Granted 21,750 shares
@ $0 |
|
02/16/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Granted 63,000 shares
@ $0 |
|
02/07/2018 |
4
| BIGHAM MICHAEL (Chairman and CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns:
| Sold 4,000 shares
@ $14.22, valued at
$56.9k
|
|
|